Estados Unidos · Plataformas y datos · MarketBeat

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Stock Has Average Target Price of $699.20 According to Analysts

Publicado por MarketBeat · Estados Unidos hace 1 h

Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL - Get Free Report) have received an average rating of "Moderate Buy" from the eighteen ratings firms that are currently…

Leer el artículo completo en MarketBeat Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.marketbeat.com)

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Stock Has Average Target Price of $699.20 According to Analysts

También te puede interesar

It’s a rough housing market, and Goldman Sachs expects it to get worse

President Donald Trump Claims, "We Don't Have Inflation, and Tariffs Don't Cause Inflation," but a New Report Strongly Disagrees

U.S. to allow 'dark fleet' tankers to ship oil legally

France imposes curfews in parts of Paris, other cities after weekend of riots

The world’s finance chiefs see new risks — and less China angst

AO+ Probiotic Topical Mist Returns -- Now in Two New Higher-Concentration Formulas

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Stock Has Average Target Price of $699.20 According to Analysts

Compartir

También te puede interesar

It’s a rough housing market, and Goldman Sachs expects it to get worse

President Donald Trump Claims, "We Don't Have Inflation, and Tariffs Don't Cause Inflation," but a New Report Strongly Disagrees

U.S. to allow 'dark fleet' tankers to ship oil legally

France imposes curfews in parts of Paris, other cities after weekend of riots

The world’s finance chiefs see new risks — and less China angst

AO+ Probiotic Topical Mist Returns -- Now in Two New Higher-Concentration Formulas